Jose Lutzky, Md

This study tested whether combining two immunotherapy drugs, nivolumab and relatlimab, could shrink tumors in people with metastatic uveal melanoma, a rare eye cancer that has spread. 27 adults who had not received certain prior treatments took part. The goal was to see how many …